Adaptive Biotechnologies Q1 Loss Narrows

Adaptive Biotechnologies reported a first-quarter net loss of $20.03 million, or $0.13 per share, improving from a $29.6 million loss, or $0.20 per share, a year earlier. The article is a straightforward earnings update with no additional guidance or operational details. The narrower loss is modestly constructive, but the release is largely neutral for the stock.

Analysis

Adaptive Biotechnologies reported a first-quarter net loss of $20.03 million, or $0.13 per share, improving from a $29.6 million loss, or $0.20 per share, a year earlier. The article is a straightforward earnings update with no additional guidance or operational details. The narrower loss is modestly constructive, but the release is largely neutral for the stock.